Cite

HARVARD Citation

    Dawoud, N. et al. (n.d.). COMBINATION USTEKINUMAB AND VEDOLIZUMAB THERAPY FOR REFRACTORY INFLAMMATORY BOWEL DISEASE: A SINGLE INSTITUTION CASE SERIES. Inflammatory bowel diseases. pp. S103-S104. [Online]. 
  
Back to record